General

DCGI Approves Study On Covaxin & Covishield Mixing

Author : NewsGram Desk

The Drugs Controller General of India (DCGI) has given a green signal for the task of conducting a study on the mixing of India's two main COVID-19 vaccines, Covaxin and Covishield, news agency ANI reported on Wednesday, 11 August.

A Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) on July 29, recommended for conducting this study on mixing of the two shots.

The expert committee recommended granting permission to CMC, Vellore, for conducting the Phase-4 clinical trial which may conduct the study on 300 healthy volunteers by administered a dose of each of Covaxin and Covishield.

However, the DCGI's approval for the study on mixing the vaccines is different from the recent study of the Indian Council of Medical Research (ICMR) which concluded that combining two different shots is "safe and effective".

Subscribe to our channels on YouTube and WhatsApp

Download our app on Play Store

Also Read

Flydubai Attack Feeds into Netanyahu’s ‘Protector’ Narrative with Crucial Elections Approaching

Former US Diplomat Fried Warns Mixed Signals Could Undercut Russia Sanctions

40 Years Before Captain Smit Machchhar’s Bravery, One Flight Attendant Died Saving More Than 300 Passengers During 1986 Pan Am Hijacking—She Was Neerja Bhanot

“Shameful Act by Government Hospital”: Bhadohi Woman Gives Birth Outside Hospital After Allegedly Being Denied Admission Over Caste

Gujarat Police Registers FIR Against Three Recognized Unregistered Political Parties; Alleges Crores of Tax-Evasion Fraud